Background: Risks and costs of allogeneic blood transfusions mandate strategies to reduce blood loss in surgery. The objective of this study was to assess the efficacy of antifibrinolytic treatment in reducing perioperative blood loss during total knee replacement.
Methods: A double-blind, randomized and placebo-controlled clinical trial was carried out on 127 patients undergoing total knee replacement.